These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25174716)

  • 1. The pterocarpanquinone LQB-118 induces apoptosis in acute myeloid leukemia cells of distinct molecular subtypes and targets FoxO3a and FoxM1 transcription factors.
    Nestal de Moraes G; Castro CP; Salustiano EJ; Dumas ML; Costas F; Lam EW; Costa PR; Maia RC
    Int J Oncol; 2014 Nov; 45(5):1949-58. PubMed ID: 25174716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The therapeutical potential of a novel pterocarpanquinone LQB-118 to target inhibitor of apoptosis proteins in acute myeloid leukemia cells.
    de Souza Reis FR; de Faria FC; Castro CP; de Souza PS; da Cunha Vasconcelos F; Bello RD; da Silva AJ; Costa PR; Maia RC
    Anticancer Agents Med Chem; 2013 Feb; 13(2):341-51. PubMed ID: 22721384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pterocarpanquinone LQB‑118 compound induces apoptosis of cytarabine‑resistant acute myeloid leukemia cells.
    Hancio T; Mazzoccoli L; Guimarães G; Robaina M; Mendonça BDS; Nestal De Moraes G; Monte-Mor BDCR; Mayumi Gutiyama L; De Carvalho LO; Netto CD; Costa PRR; De Faria FCC; Maia RC
    Int J Oncol; 2021 Jun; 58(6):. PubMed ID: 33786613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The FOXM1 transcriptional factor promotes the proliferation of leukemia cells through modulation of cell cycle progression in acute myeloid leukemia.
    Nakamura S; Hirano I; Okinaka K; Takemura T; Yokota D; Ono T; Shigeno K; Shibata K; Fujisawa S; Ohnishi K
    Carcinogenesis; 2010 Nov; 31(11):2012-21. PubMed ID: 20823107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of FoxM1 transcription factor contributes to curcumin-induced inhibition of survival, angiogenesis, and chemosensitivity in acute myeloid leukemia cells.
    Zhang JR; Lu F; Lu T; Dong WH; Li P; Liu N; Ma DX; Ji CY
    J Mol Med (Berl); 2014 Dec; 92(12):1319-30. PubMed ID: 25179295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tumor suppressive role of miRNA-370 by targeting FoxM1 in acute myeloid leukemia.
    Zhang X; Zeng J; Zhou M; Li B; Zhang Y; Huang T; Wang L; Jia J; Chen C
    Mol Cancer; 2012 Aug; 11():56. PubMed ID: 22900969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LQB-118, a pterocarpanquinone structurally related to lapachol [2-hydroxy-3-(3-methyl-2-butenyl)-1,4-naphthoquinone]: a novel class of agent with high apoptotic effect in chronic myeloid leukemia cells.
    Maia RC; Vasconcelos FC; de Sá Bacelar T; Salustiano EJ; da Silva LF; Pereira DL; Moellman-Coelho A; Netto CD; da Silva AJ; Rumjanek VM; Costa PR
    Invest New Drugs; 2011 Dec; 29(6):1143-55. PubMed ID: 20499132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pterocarpanquinone LQB-118 inhibits tumor cell proliferation by downregulation of c-Myc and cyclins D1 and B1 mRNA and upregulation of p21 cell cycle inhibitor expression.
    Martino T; Magalhães FC; Justo GA; Coelho MG; Netto CD; Costa PR; Sabino KC
    Bioorg Med Chem; 2014 Jun; 22(12):3115-22. PubMed ID: 24794748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pterocarpanquinone LQB 118 induces apoptosis in tumor cells through the intrinsic pathway and the endoplasmic reticulum stress pathway.
    de Sá Bacelar T; da Silva AJ; Costa PR; Rumjanek VM
    Anticancer Drugs; 2013 Jan; 24(1):73-83. PubMed ID: 22960938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into the Biological Evaluation of Pterocarpanquinones and Carbapterocarpans with Anti-tumor Activity against MDR Leukemias.
    Rumjanek VM; Maia RC; Salustiano EJ; Costa PRR
    Anticancer Agents Med Chem; 2019; 19(1):29-37. PubMed ID: 29692266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WTIP upregulates FOXO3a and induces apoptosis through PUMA in acute myeloid leukemia.
    Zhu Y; Tong X; Wang Y; Lu X
    Cell Death Dis; 2021 Dec; 13(1):18. PubMed ID: 34930905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXM1 contributes to treatment failure in acute myeloid leukemia.
    Khan I; Halasi M; Patel A; Schultz R; Kalakota N; Chen YH; Aardsma N; Liu L; Crispino JD; Mahmud N; Frankfurt O; Gartel AL
    JCI Insight; 2018 Aug; 3(15):. PubMed ID: 30089730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Aurora A kinase activity with the investigational agent alisertib increases the efficacy of cytarabine through a FOXO-dependent mechanism.
    Kelly KR; Nawrocki ST; Espitia CM; Zhang M; Yang JJ; Padmanabhan S; Ecsedy J; Giles FJ; Carew JS
    Int J Cancer; 2012 Dec; 131(11):2693-703. PubMed ID: 22488249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypomethylating agents reactivate FOXO3A in acute myeloid leukemia.
    Thépot S; Lainey E; Cluzeau T; Sébert M; Leroy C; Adès L; Tailler M; Galluzzi L; Baran-Marszak F; Roudot H; Eclache V; Gardin C; de Botton S; Auberger P; Fenaux P; Kroemer G; Boehrer S
    Cell Cycle; 2011 Jul; 10(14):2323-30. PubMed ID: 21654193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The orally active pterocarpanquinone LQB-118 exhibits cytotoxicity in prostate cancer cell and tumor models through cellular redox stress.
    Martino T; Kudrolli TA; Kumar B; Salviano I; Mencalha A; Coelho MGP; Justo G; Costa PRR; Sabino KCC; Lupold SE
    Prostate; 2018 Feb; 78(2):140-151. PubMed ID: 29105806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. U2AF1 mutation promotes tumorigenicity through facilitating autophagy flux mediated by FOXO3a activation in myelodysplastic syndromes.
    Zhu Y; Song D; Guo J; Jin J; Tao Y; Zhang Z; Xu F; He Q; Li X; Chang C; Wu L
    Cell Death Dis; 2021 Jun; 12(7):655. PubMed ID: 34183647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells.
    Rao J; Xu DR; Zheng FM; Long ZJ; Huang SS; Wu X; Zhou WH; Huang RW; Liu Q
    J Transl Med; 2011 May; 9():71. PubMed ID: 21595920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Over-expression of FoxM1 is associated with adverse prognosis and FLT3-ITD in acute myeloid leukemia.
    Liu LL; Zhang DH; Mao X; Zhang XH; Zhang B
    Biochem Biophys Res Commun; 2014 Mar; 446(1):280-5. PubMed ID: 24582753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circ-PTK2 promotes the proliferation and suppressed the apoptosis of acute myeloid leukemia cells through targeting miR-330-5p/FOXM1 axis.
    Yi L; Zhou L; Luo J; Yang Q
    Blood Cells Mol Dis; 2021 Feb; 86():102506. PubMed ID: 33126007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXM1 regulates leukemia stem cell quiescence and survival in MLL-rearranged AML.
    Sheng Y; Yu C; Liu Y; Hu C; Ma R; Lu X; Ji P; Chen J; Mizukawa B; Huang Y; Licht JD; Qian Z
    Nat Commun; 2020 Feb; 11(1):928. PubMed ID: 32066721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.